Skip to Content

Chlorpheniramine / methscopolamine / phenylephrine / pseudoephedrine Pregnancy and Breastfeeding Warnings

Chlorpheniramine / methscopolamine / phenylephrine / pseudoephedrine is also known as: AlleRx Dose Pack

Chlorpheniramine / methscopolamine / phenylephrine / pseudoephedrine Pregnancy Warnings

Chlorpheniramine/methscopolamine/PE/PSE has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Chlorpheniramine/dextromethorphan/PE/PSE is only recommended for use during pregnancy when benefit outweighs risk.

See references

Chlorpheniramine / methscopolamine / phenylephrine / pseudoephedrine Breastfeeding Warnings

There are no data on the excretion of chlorpheniramine/methscopolamine/PE/PSE into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. AlleRx Dose Pack (chlorpheniramine/methscopolamine/PE/PSE)." Cornerstone BioPharma Inc, Cary, NC.

References for breastfeeding information

  1. "Product Information. AlleRx Dose Pack (chlorpheniramine/methscopolamine/PE/PSE)." Cornerstone BioPharma Inc, Cary, NC.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide